[Cytomegalovirus cholestasis in an immunocompetent host]

Ann Biol Clin (Paris). 2019 Jun 1;77(3):323-326. doi: 10.1684/abc.2019.1434.
[Article in French]

Abstract

Primary infection or reactivation of cytomegalovirus (CMV) can induce in immunocompromised patients a severe disease depending on the type of immuno-suppression, and can affect multiple organs. On the other hand, the infection is benign and mostly asymptomatic in immunocompetent individuals who do not require antiviral treatment. Rare cases of primary infection have been documented. In this article, we report the case of a 21-year-old immunocompetent female patient with CMV cholestatic jaundice. The diagnosis was retained on all clinico-pathologic data after eliminating the autoimmune, surgical and other infectious causes. Resolution of cholestasis has been observed with ganciclovir.

Keywords: cholestasis; cytomegalovirus; ganciclovir; immunocompetent; infection.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cholestasis / diagnosis
  • Cholestasis / drug therapy
  • Cholestasis / immunology
  • Cholestasis / virology*
  • Cytomegalovirus Infections / complications*
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / immunology
  • Female
  • Ganciclovir / therapeutic use
  • Humans
  • Immunocompetence*
  • Young Adult

Substances

  • Antiviral Agents
  • Ganciclovir